Login / Signup

Successful treatment of severe refractory autoimmune hemolytic anemia after hematopoietic stem cell transplant with abatacept.

Jennifer HessLeon SuFrank NizziKristen BeebeKyrie MageeDana SalzbergJennifer StahleckerHolly K MillerRoberta H AdamsAlexander Ngwube
Published in: Transfusion (2018)
Abatacept may provide significant clinical benefit in the management of AIHA after HSCT.
Keyphrases
  • hematopoietic stem cell
  • rheumatoid arthritis
  • rheumatoid arthritis patients
  • chronic kidney disease
  • multiple sclerosis
  • drug induced
  • early onset
  • systemic lupus erythematosus